China Medical & HealthCare Group Limited
COLRF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $783,132 | $805,670 | $821,529 | $838,925 |
| % Growth | -2.8% | -1.9% | -2.1% | – |
| Cost of Goods Sold | $633,181 | $654,743 | $647,903 | $714,296 |
| Gross Profit | $149,951 | $150,927 | $173,626 | $124,629 |
| % Margin | 19.1% | 18.7% | 21.1% | 14.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $107,864 | $114,791 | $108,891 | $112,591 |
| SG&A Expenses | $111,535 | $127,636 | $112,466 | $115,628 |
| Sales & Mktg Exp. | $3,671 | $3,296 | $3,575 | $3,037 |
| Other Operating Expenses | $3,087 | -$1,035 | -$632 | $0 |
| Operating Expenses | $114,622 | $126,601 | $111,834 | $99,234 |
| Operating Income | $35,329 | $24,326 | $61,792 | $53,579 |
| % Margin | 4.5% | 3% | 7.5% | 6.4% |
| Other Income/Exp. Net | -$11,715 | -$13,407 | -$15,707 | -$20,977 |
| Pre-Tax Income | $23,614 | $10,919 | $46,085 | $32,602 |
| Tax Expense | $1,130 | -$1,976 | $17,004 | $12,674 |
| Net Income | $1,526 | $7,114 | $21,659 | $13,050 |
| % Margin | 0.2% | 0.9% | 2.6% | 1.6% |
| EPS | 0.001 | 0.007 | 0.02 | 0.012 |
| % Growth | -78.8% | -66.8% | 65.8% | – |
| EPS Diluted | 0.001 | 0.007 | 0.02 | 0.012 |
| Weighted Avg Shares Out | 1,084,072 | 1,085,987 | 1,086,045 | 1,086,005 |
| Weighted Avg Shares Out Dil | 1,083,982 | 1,085,987 | 1,086,005 | 1,086,005 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2,351 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $21,287 |
| Depreciation & Amortization | $5,753 | $43,582 | $45,512 | $46,268 |
| EBITDA | $13,515 | $79,759 | $106,989 | $99,847 |
| % Margin | 1.7% | 9.9% | 13% | 11.9% |